Año: 2019
Journal Impact Factor (JIF): 2.9840
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | SCIE | 42/92 | Q2 | T2 | D5 |
| PHARMACOLOGY & PHARMACY | SCIE | 111/271 | Q2 | T2 | D5 |
Año: 2019
Journal Citation Indicator (JCI): 0,840
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 47/117 | Q2 | T2 | D4 | 60,26 |
| PHARMACOLOGY & PHARMACY | 127/353 | Q2 | T2 | D4 | 64,16 |
Año:
2019
CiteScore:
2,400
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 163/283 | Q3 | T2 | D6 |
| Pharmacology (medical) | 134/237 | Q3 | T2 | D6 |
| Pharmacology | 187/301 | Q3 | T2 | D7 |
SJR año:
2019
Factor de Impacto:
0,966
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology | 82/349 | Q1 | T1 | D3 |
| Pharmacology (medical) | 66/301 | Q2 | T1 | D3 |
| Infectious Diseases | 108/336 | Q2 | T1 | D4 |
| Agencia | Código de Proyecto |
|---|---|
| AstraZeneca | - |
| Pfizer | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Peeters, Pascale | IQVIA Inc. (United States) |
| 2 | Ryan, Kellie | AstraZeneca (United Kingdom) |
| 3 | Karve, Sudeep | AstraZeneca (United Kingdom) |
| 4 | Potter, Danielle | AstraZeneca (United Kingdom) |
| 5 | Baelen, Elisa | IQVIA Inc. (United States) |
| 6 | Rojas-Farreras, Sonia | IQVIA Inc. (United States) |
| 7 | Hospital Universitario Virgen Macarena (Spain) |